Shinya Hirata

1.5k total citations
44 papers, 1.1k citations indexed

About

Shinya Hirata is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Shinya Hirata has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 17 papers in Oncology and 16 papers in Molecular Biology. Recurrent topics in Shinya Hirata's work include Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (11 papers). Shinya Hirata is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (11 papers). Shinya Hirata collaborates with scholars based in Japan, Germany and United States. Shinya Hirata's co-authors include Yasuharu Nishimura, Satoru Senju, Hidetake Matsuyoshi, Yasushi Uemura, Daiki Fukuma, Hideo Baba, Satoshi Fukushima, Yusuke Matsunaga, Yutaka Motomura and Mitsuhiro Inoue and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Shinya Hirata

41 papers receiving 1.1k citations

Peers

Shinya Hirata
Kohta Miyawaki Japan
Shunyou Gong United States
Daniel T. Patton United Kingdom
Biancamaria Ricci Italy
Caroline Johnson‐Léger Switzerland
Kaisa Auvinen Finland
Brandy Perkins United States
Jason Foley United States
Miriam Fogli Italy
Ariel Madrigal United States
Kohta Miyawaki Japan
Shinya Hirata
Citations per year, relative to Shinya Hirata Shinya Hirata (= 1×) peers Kohta Miyawaki

Countries citing papers authored by Shinya Hirata

Since Specialization
Citations

This map shows the geographic impact of Shinya Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinya Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinya Hirata more than expected).

Fields of papers citing papers by Shinya Hirata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinya Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinya Hirata. The network helps show where Shinya Hirata may publish in the future.

Co-authorship network of co-authors of Shinya Hirata

This figure shows the co-authorship network connecting the top 25 collaborators of Shinya Hirata. A scholar is included among the top collaborators of Shinya Hirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinya Hirata. Shinya Hirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koide, Hiroyuki, Shinya Hirata, Hiroki Ochiai, et al.. (2025). In vivo delivery of antioxidant enzymes with multi-functionalized lipid nanoparticles for sepsis therapy. Journal of Controlled Release. 382. 113734–113734. 1 indexed citations
2.
Hagemeijer, Marne C., et al.. (2024). A 37-Year-Old Man With Intellectual Disability Discovered to Have Aspartylglucosaminuria. Neurology Genetics. 10(3).
3.
Furuta, Yoki, Hideaki Naoe, Katsuya Nagaoka, et al.. (2023). Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment. Journal of Clinical Medicine. 12(9). 3131–3131. 1 indexed citations
4.
Uekawa, Ken, Yasuyuki Kaku, Hiroaki Matsuzaki, et al.. (2020). Intracranial and extracranial multiple arterial dissecting aneurysms in rheumatoid arthritis: A case report. Interventional Neuroradiology. 27(2). 212–218. 4 indexed citations
5.
Tanaka, Yoshihiro, Atsuko Yamada, Shinya Hirata, et al.. (2019). Efficacy and Safety of Enoxaparin for Prophylaxis of Postoperative Venous Thromboembolism After Esophagectomy: A Single-center Prospective Randomized Controlled Phase II Study. Anticancer Research. 39(5). 2615–2625. 18 indexed citations
6.
Nishimura, Nao, Shinya Endo, Shikiko Ueno, et al.. (2017). A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo. Biochemical and Biophysical Research Communications. 486(4). 916–922. 2 indexed citations
7.
Kozako, Tomohiro, Shuhei Soeda, Makoto Yoshimitsu, et al.. (2016). Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T‐cell leukemia cells. FEBS Open Bio. 6(5). 442–460. 33 indexed citations
8.
Endo, Shinya, Masayuki Amano, Nao Nishimura, et al.. (2015). Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cells. Biochemical and Biophysical Research Communications. 469(2). 236–242. 12 indexed citations
9.
Ikeda, Tokunori, Shinya Hirata, Koutaro Takamatsu, et al.. (2014). Suppression of Th1-Mediated Autoimmunity by Embryonic Stem Cell-Derived Dendritic Cells. PLoS ONE. 9(12). e115198–e115198. 11 indexed citations
10.
Kozako, Tomohiro, Shinya Hirata, Yoshitaka Shimizu, et al.. (2011). Oligomannose‐coated liposomes efficiently induce human T‐cell leukemia virus‐1‐specific cytotoxic T lymphocytes without adjuvant. FEBS Journal. 278(8). 1358–1366. 22 indexed citations
11.
12.
Senju, Satoru, Shinya Hirata, Yutaka Motomura, et al.. (2010). Pluripotent stem cells as source of dendritic cells for immune therapy. International Journal of Hematology. 91(3). 392–400. 23 indexed citations
13.
Fukushima, Satoshi, Shinya Hirata, Yutaka Motomura, et al.. (2009). Multiple Antigen-targeted Immunotherapy With α-Galactosylceramide–loaded and Genetically Engineered Dendritic Cells Derived From Embryonic Stem Cells. Journal of Immunotherapy. 32(3). 219–231. 22 indexed citations
14.
Imai, Katsunori, Shinya Hirata, Atsushi Irie, et al.. (2008). Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers. Clinical Cancer Research. 14(20). 6487–6495. 90 indexed citations
15.
16.
Harao, Michiko, Shinya Hirata, Atsushi Irie, et al.. (2008). HLA‐A2‐restricted CTL epitopes of a novel lung cancer‐associated cancer testis antigen, cell division cycle associated 1, can induce tumor‐reactive CTL. International Journal of Cancer. 123(11). 2616–2625. 71 indexed citations
17.
Hirata, Shinya, Hidetake Matsuyoshi, Daiki Fukuma, et al.. (2007). Involvement of Regulatory T Cells in the Experimental Autoimmune Encephalomyelitis-Preventive Effect of Dendritic Cells Expressing Myelin Oligodendrocyte Glycoprotein plus TRAIL. The Journal of Immunology. 178(2). 918–925. 42 indexed citations
18.
19.
Fukuma, Daiki, Hidetake Matsuyoshi, Shinya Hirata, et al.. (2005). Cancer prevention with semi-allogeneic ES cell-derived dendritic cells. Biochemical and Biophysical Research Communications. 335(1). 5–13. 27 indexed citations
20.
Matsuyoshi, Hidetake, Satoru Senju, Shinya Hirata, et al.. (2004). Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination. The Journal of Immunology. 172(2). 776–786. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kohta Miyawaki Breakdown of academic impact, for papers by Shunyou Gong Breakdown of academic impact, for papers by Daniel T. Patton Breakdown of academic impact, for papers by Biancamaria Ricci Breakdown of academic impact, for papers by Caroline Johnson‐Léger Breakdown of academic impact, for papers by Kaisa Auvinen Breakdown of academic impact, for papers by Brandy Perkins Breakdown of academic impact, for papers by Jason Foley Breakdown of academic impact, for papers by Miriam Fogli Breakdown of academic impact, for papers by Ariel Madrigal
Rankless by CCL
2026